Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes.
about
Thrombolytic therapy for pulmonary embolismContribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary EmbolismPast, present and future of emergency care research.Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.
P2860
Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Rationale and methodology for ...... udes quality of life outcomes.
@en
Rationale and methodology for ...... udes quality of life outcomes.
@nl
type
label
Rationale and methodology for ...... udes quality of life outcomes.
@en
Rationale and methodology for ...... udes quality of life outcomes.
@nl
prefLabel
Rationale and methodology for ...... udes quality of life outcomes.
@en
Rationale and methodology for ...... udes quality of life outcomes.
@nl
P2093
P2860
P356
P1476
Rationale and methodology for ...... ludes quality of life outcomes
@en
P2093
Alan E Jones
D Mark Courtney
Deborah B Diercks
Jackeline Hernandez
James R Klinger
Jeffrey A Kline
Kristen E Nordenholz
Matthew T Rondina
Melanie M Hogg
P2860
P304
P356
10.1111/1742-6723.12159
P577
2013-11-13T00:00:00Z